I agree that this site is using cookies. You can find further informations here.
X
Iwamoto, Shigeyoshi
42  results:
Search for persons X
?
1

Impact of early tumor shrinkage on quality of life in patie..:

Ooki, Akira ; Morita, Satoshi ; Tsuji, Akihito...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

Efficacy of celecoxib as preemptive analgesia for patients ..:

Saito, Takuya ; Iwamoto, Shigeyoshi ; Murotani, Kenta...
Surgery Today.  51 (2021)  7 - p. 1118-1125 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Disagreement between patient‐ and physician‐reported outcom..:

Ooki, Akira ; Morita, Satoshi ; Tsuji, Akihito...
Cancer Medicine.  9 (2020)  24 - p. 9419-9430 , 2020
Link: https://doi.org/10.1002/..
 
?
4

Evaluation of FOLFOX or CAPOX reintroduction with or withou..:

Kotaka, Masahito ; Iwamoto, Shigeyoshi ; Satake, Hironaga...
International Journal of Clinical Oncology.  25 (2020)  8 - p. 1515-1522 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Patient‐reported symptom burden as a prognostic factor in t..:

Ooki, Akira ; Morita, Satoshi ; Iwamoto, Shigeyoshi...
Cancer Medicine.  9 (2020)  5 - p. 1779-1789 , 2020
Link: https://doi.org/10.1002/..
 
?
6

Phase II study of 5-fluorouracil–leucovorin plus bevacizuma..:

Ohta, Takashi ; Kato, Takeshi ; Kawakami, Hisato...
International Journal of Clinical Oncology.  25 (2020)  7 - p. 1291-1298 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Multicenter open-label randomized phase II study of second-..:

Nagata, Naoki ; Maeda, Hiromichi ; Ishibashi, Keiichiro...
Medical Oncology.  36 (2019)  6 - p. , 2019
Link: https://doi.org/10.1007/..
 
?
8

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bev..:

Oki, Eiji ; Kato, Takeshi ; Bando, Hideaki...
Clinical Colorectal Cancer.  17 (2018)  2 - p. 147-155 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line..:

Iwamoto, Shigeyoshi ; Maeda, Hiromichi ; Hazama, Shoichi...
Journal of Cancer.  9 (2018)  22 - p. 4092-4098 , 2018
Link: https://doi.org/10.7150/..
 
?
10

A prospective Phase II study to examine the relationship be..:

Iwamoto, Shigeyoshi ; Ooki, Akira ; Morita, Satoshi...
Cancer Medicine.  7 (2018)  9 - p. 4217-4227 , 2018
Link: https://doi.org/10.1002/..
 
?
11

Early drop in serum lactate dehydrogenase concentrations as..:

Iwamoto, Shigeyoshi ; Maeda, Hiromichi ; Morita, Satoshi...
Annals of Cancer Research and Therapy.  25 (2017)  2 - p. 95-99 , 2017
Link: https://doi.org/10.4993/..
 
?
12

S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 ..:

Baba, Hideo ; Yamada, Yasuhide ; Takahari, Daisuke...
ESMO Open.  2 (2017)  1 - p. e000135 , 2017
Link: https://doi.org/10.1136/..
 
?
13

Retrospective analysis of bevacizumab‐induced hypertension ..:

Nakaya, Aya ; Kurata, Takayasu ; Yokoi, Takashi...
Cancer Medicine.  5 (2016)  7 - p. 1381-1387 , 2016
Link: https://doi.org/10.1002/..
 
?
14

A Phase II Study of XELOX and Cetuximab as First-Line Thera..:

Hazama, Shoichi ; Maeda, Hiromichi ; Iwamoto, Shigeyoshi...
Clinical Colorectal Cancer.  15 (2016)  4 - p. 329-336 , 2016
Link: https://doi.org/10.1016/..
 
?
15

A single-arm Phase II validation study of preventing oxalip..:

Yoshida, Yoichiro ; Hirata, Keiji ; Matsuoka, Hiroshi...
Drug Design, Development and Therapy.  , 2015
Link: https://doi.org/10.2147/..
 
1-15